🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

5+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 5 of 5 recruiting trials for “poorly-differentiated-thymic-neuroendocrine-carcinoma”

NARecruitingNCT07068542 ↗

Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer

👨‍⚕️ Minghua Ge, Zhejiang Provincial People's Hospital📍 1 site📅 Started Jul 2025View details ↗
Phase 3RecruitingNCT06860971 ↗

A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

🏥 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.📍 35 sites📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06440850 ↗

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation

👨‍⚕️ Sasan Fazeli, City of Hope Medical Center📍 1 site📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06359847 ↗

Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

👨‍⚕️ Yansong Lin, Ph D, Peking Union Medical College Hospital📍 1 site📅 Started Nov 2023View details ↗
RecruitingNCT05994365 ↗

Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma

🏥 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.📍 3 sites📅 Started Aug 2023View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →